State of New Jersey Common Pension Fund D trimmed its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 1.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 42,831 shares of the company’s stock after selling 651 shares during the period. State of New Jersey Common Pension Fund D’s holdings in Clorox were worth $6,956,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors also recently bought and sold shares of the business. Insight Folios Inc lifted its holdings in Clorox by 3.0% during the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock worth $358,000 after buying an additional 63 shares during the last quarter. HCR Wealth Advisors lifted its holdings in Clorox by 1.0% during the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock worth $1,116,000 after buying an additional 68 shares during the last quarter. Empower Advisory Group LLC lifted its holdings in Clorox by 4.5% during the 3rd quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock worth $297,000 after buying an additional 78 shares during the last quarter. Aviance Capital Partners LLC lifted its holdings in Clorox by 2.7% during the 3rd quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock worth $502,000 after buying an additional 80 shares during the last quarter. Finally, Lindbrook Capital LLC lifted its holdings in Clorox by 9.9% during the 3rd quarter. Lindbrook Capital LLC now owns 977 shares of the company’s stock worth $159,000 after buying an additional 88 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.
Clorox Stock Performance
NYSE CLX opened at $148.11 on Wednesday. The company has a current ratio of 0.94, a quick ratio of 0.62 and a debt-to-equity ratio of 20.52. The business’s 50 day moving average is $158.78 and its two-hundred day moving average is $159.71. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The stock has a market capitalization of $18.33 billion, a price-to-earnings ratio of 40.47, a PEG ratio of 2.52 and a beta of 0.42.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on the company. Wells Fargo & Company boosted their target price on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Barclays boosted their target price on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a report on Wednesday, February 5th. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Finally, JPMorgan Chase & Co. boosted their target price on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. Four equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $158.21.
Check Out Our Latest Report on Clorox
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- How to Invest in the Best Canadian Stocks
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- What is the NASDAQ Stock Exchange?
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- Golden Cross Stocks: Pattern, Examples and Charts
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.